Rapid detection of Mycobacterium tuberculosis by recombinase polymerase amplification. [PDF]
, 2014 Improved access to effective tests for diagnosing tuberculosis (TB) has been designated a public health priority by the World Health Organisation. In high burden TB countries nucleic acid based TB tests have been restricted to centralised laboratories ...
Boyle, David S +9 more
core +4 more sources
"Why me, why now?" Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infection [PDF]
, 2016 BACKGROUND: The prevalence of nontuberculous mycobacterial (NTM) disease is rising. An understanding of known risk factors for disease sheds light on the immunological and physical barriers to infection, and how and why they may be overcome.
Lake, MA +3 more
core
Pulmonary Mycobacterium avium-intracellulare is the main driver of the rise in non-tuberculous mycobacteria incidence in England, Wales and Northern Ireland, 2007–2012 [PDF]
, 2016 BACKGROUND: The incidence of non-tuberculous mycobacteria (NTM) isolation from humans is increasing worldwide. In England, Wales and Northern Ireland (EW&NI) the reported rate of NTM more than doubled between 1996 and 2006.
H. Lucy Thomas +7 more
core +1 more source
BMC Pulmonary Medicine, 2007 Background Current systemic therapy for nontuberculous mycobacterial pulmonary infection is limited by poor clinical response rates, drug toxicities and side effects.
Jacobs Susan S +3 more
doaj +1 more source
Indagine sulla presenza di Map in allevamenti di bovine da latte nella provincia della Spezia [PDF]
, 2014 Mycobacterium avium paratuberculosis ( Map) è l'agente eziologico che causa una enterite granulomatosa progressiva cronica conosciuta come paratubercolosi o malattia di Johne, la quale colpisce principalmente i ruminanti domestici e selvatici.
ZANNARDI, ERIKA
core
Automated quantitative drug susceptibility testing of non-tuberculous mycobacteria using MGIT 960/EpiCenter TB eXiST [PDF]
, 2017 Objectives To assess the predictive value of in vitro drug susceptibility testing (DST) in slow-growing non-tuberculous mycobacteria (NTM), knowledge on quantitative levels of drug susceptibility should be available.
Böttger, Erik C. +4 more
core
TUBERCULOSIS GANGLIONAR RETROPERITONEAL Y MESENTERICA: CASO CLINICO
Revista Chilena de Radiología, 2004 Se describen las características del compromiso ganglionar por Mycobacterium tuberculosis en un paciente con SIDA en quien se demuestra alteraciones de linfonódulos retroperitoneales y mesentéricos en tomografía computada.
Rafael Martínez F +4 more
doaj
Study on environmental mycobacteria obtained from South Indian BCG trial area [PDF]
, 1998 Non Tuberculous Mycobacteria (NTM) are widely distributed in our environment and man is being constantly exposed to these organisms by various means(l).
Paramasivan, C N
core
Comparative in-vitro activity of fleroxacin and other 6-fluoroquinolones against mycobacteria [PDF]
, 2017 The susceptibility of 11 clinical isolates of Mycobacterium tuberculosis, 3 M. kansasii,3 M. xenopi, 2 M.scrofulaceum, 2 M. marinum, 2 M. malmoense to fleroxacin,ciprofloxacin, norfloxacin, rifampicin, isoniazid, ethambutol, and streptomycin was ...
Hohl, Peter +2 more
core
Canadian Journal of Infectious Diseases and Medical MicrobiologyMycobacterium avium complex (MAC) infection is a growing public health concern worldwide, particularly affecting the elderly and immunocompromised population.
Jeong-Gyu Choi +16 more
doaj +1 more source